Aveanna Healthcare Holdings Inc.

AVAH Healthcare Medical Care Facilities

Aveanna Healthcare Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.4 billion, up 20.2% from fiscal 2024. In the quarter to June 2026, revenue grew 13.7%, EPS grew 46.2%, free cash flow grew 57.9% and total debt rose 1.07%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

12.34 0.30 −2.37%
Market cap
$2.8B
P/E
9.5×
Fwd P/E
10.4×
Dividend yield
—
F-score
7/9
Altman Z
1.45
Beneish M
−2.10
Dividend safety
n/a

Aveanna Healthcare Holdings Inc. (AVAH) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, Aveanna Healthcare Holdings Inc. (AVAH) trades at a EV/Sales of 1.6×. Over the past ten years it has ranged from 0.9× (December 2022) to 1.9× (June 2021); the current reading is higher than 93% of that period. That is above the Medical Care Facilities industry median of 1.3× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 1.2× 8.67%
FY2024 1.1× 9.50%
FY2023 1.0× 17.44%
FY2022 0.9× (44.01%)
FY2021 1.5× (14.64%)
FY2020 1.8× 0.00%
FY2019 1.8× 0.00%
FY2018 1.8× —

Quarterly newest first

Period EV/Sales Change
Jun 2026 1.2× 17.95%
Mar 2026 1.1× (12.70%)
Dec 2025 1.2× (12.99%)
Sep 2025 1.4× 25.88%
22 more quarters

Against its own ten years

Low 0.9× High 1.9×
Ten-year median 1.1×
Current reading's percentile 93

EV/Sales against peers

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on AVAH